switching to retatrutide from tirzepatide moving Retatrutide: The Complete Transition Guide switching from retatrutide to tirzepatide

Zheng Z K, Zong Y, Ma Y Y, et al

A vial that's only 95% pure means 5% of what you're administering is an unknown variable

Cantoni, G

Symptoms include severe, persistent abdominal pain radiating to the back, often accompanied by nausea and vomiting that differs qualitatively from the typical GI side effects

Dose adjustment considerations: If gastrointestinal symptoms are severe or persistent despite these measures, contact your prescribing clinician to discuss: Slowing the dose escalation schedule Temporarily reducing the dose Taking a brief treatment pause (though this may affect weight loss progress) Switching to an alternative weight management medication if symptoms are intolerable The STEP trials demonstrated that slower dose titration can reduce the incidence and severity of gastrointestinal adverse effects